» Articles » PMID: 31558571

Female Sex As a Risk Factor for Ischaemic Stroke Varies with Age in Patients with Atrial Fibrillation

Overview
Journal Heart
Date 2019 Sep 28
PMID 31558571
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Female sex is an inconsistent ischaemic stroke risk factor in patients with atrial fibrillation (AF). We hypothesised that the ischaemic stroke risk varies with age among women compared with men.

Methods: We retrieved the patients with newly diagnosed AF during 2001-2013 from Taiwan's National Health Insurance Research Database. Patients with missing information, age <20 years, history of valvular heart disease and surgery, rheumatic heart disease, hyperthyroidism or anticoagulation and/or antiplatelet use were excluded. Propensity score matching (PSM) included patient comorbidities, medications and index date stratified by age and sex groups. Primary outcome was defined as ischaemic stroke at follow-up.

Results: After exclusion criteria, 87 369 men and 71 853 women remained for analysis (aged 73.1±14.4 years). After 1:1 PSM, we included 59 583 men (aged 73.5±13.7 years) and 59 583 women (aged 73.4±13.8 years) for analysis. We also stratified patients by age. The ischaemic stroke risk varied with age in women compared with men: lower in the ≤55 years (subdistribution HR (SHR)=0.75, 95% CI 0.62 to 0.90) and 56-65 years (SHR=0.87, 95% CI 0.78 to 0.98) groups, neutral in the 66-75 years group (SHR=1.01, 95% CI 0.94 to 1.08) and adverse in the >75 years group (SHR=1.14, 95% CI 1.09 to 1.19).

Conclusions: The female/male ischaemic stroke risk ratio varied with age. Only women aged >75 years had a higher risk, whereas women aged <65 years had a lower risk compared with men. These findings challenge the 'sex category' component of the CHADS-VASc score, used to make decision regarding anticoagulation treatment in AF patients.

Citing Articles

Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects.

Rienstra M, Tzeis S, Bunting K, Caso V, Crijns H, De Potter T Europace. 2024; 26(12).

PMID: 39716733 PMC: 11666470. DOI: 10.1093/europace/euae298.


Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?.

Yoshimura H, Providencia R, Finan C, Schmidt A, Lip G Europace. 2024; 26(11).

PMID: 39522169 PMC: 11574618. DOI: 10.1093/europace/euae280.


Exploring the Perioperative Use of DOACs, off the Beaten Track.

Luca F, Oliva F, Giubilato S, Abrignani M, Rao C, Cornara S J Clin Med. 2024; 13(11).

PMID: 38892787 PMC: 11172442. DOI: 10.3390/jcm13113076.


Sex differences in modifiable risk factors for stroke incidence and recurrence: the UCC-SMART study.

Rissanen I, Basten M, Exalto L, Peters S, Visseren F, Geerlings M J Neurol. 2024; 271(6):3347-3358.

PMID: 38493278 PMC: 11136802. DOI: 10.1007/s00415-024-12268-6.


Catheter ablation of symptomatic atrial fibrillation: Sex, ethnicity, and socioeconomic disparities.

Bjorkenheim A, Fengsrud E, Blomstrom-Lundqvist C Heart Rhythm O2. 2023; 3(6Part B):766-770.

PMID: 36588997 PMC: 9795262. DOI: 10.1016/j.hroo.2022.07.008.